期刊文献+

不同的血液净化模式治疗脓毒症多脏器功能衰竭患者的疗效分析

Effect analysis of different blood purification treatment on sepsis patients with mutiple organ failure
原文传递
导出
摘要 目的 探讨脉冲式高容量血液滤过(PHVHF)和连续性静脉-静脉血液滤过(CVVH)两种模式在脓毒症多脏器功能衰竭患者救治中的临床价值.方法 53 例脓毒症多脏器功能衰竭患者随机分为两组,PHVHF 组 27 例, CVVH 组 26 例.于治疗前和治疗后24 小时比较两组的循环状态(HR、MAP),肺功能改善(PO2、PO2/FiO2)尿素氮( BUN)、肌酐( SCr )的变化.结果 两组患者治疗后较治疗前体温、 BUN 及SCr 均明显下降( P〈0.01 ),但组间比较差异无统计学意义.两组治疗后较治疗前PaO2/FiO2 明显升高,PHVHF 组(253.4±55.9)vs (173±44.5); CVVH 组:(218.1±40.2)vs (178±35.3) ( P〈0.01 ),PHVHF 组较 CVVH 组氧合改善更明显( P〈0.01 ).两组治疗前后比较:HR水平变化差异无统计学意义,MAP 的改善PHVHF 组明显优于CVVH 组,差异有统计学意义.结论 PHVHF 及CVVH 两种模式均能清除炎性介质,减轻机体的炎症反应, PHVHF 较 CVVH 能更快地稳定循环,减少血管活性药物的应用,改善氧和指数,清除体内代谢废物,降低基础代谢率,最终改善脓毒症患者的预后. Objective To detect the clinical value of pulse high-volume hemofiltration (PHVHF) and Continuous veno-venous hemofiltration(CVVH) in treating sepsis patients with multiple organ failure. Methods We selected 53 sepsis patients with multiple organ failure., who were randomlydivided into two groups PHVHF group and CVVH group. The clinical outcomes between the two groups were evaluated with Circulatory state(HR、MAP),pulmonary improving state and changes of Creatinine, urea nitrogen. Results The body temperature, creatinine and urea nitrogen of all patients ofthe two groups were significantly reduced after treatment(P〈0.01),while there is no therapeutic statistical difference between PHVHF group and CVVHgroup. PaO2/FiO2 in both groups were significantly increased than before treatment, with PHVHF group was (253.4±55.9)vs (173±44.5)and CVVHgroup was(218.1±40.2)vs (178±35.3)(P〈0.01). Oxygenation improvement was more obvious in PHVHF group than in CVVH group( P〈0.01 ).There was no difference on HR, but the MAP improvement in PHVHF group was significantly better than in CVVH group, with statistical difference.Conclusion Both PHVHF and CVVH can Remove inflammatory mediators, reduce inflammatory response. PHVHF can stable circulation, reduce theuse of vasoactive drugs, improve the oxygen index, remove metabolic waste, reduce basal metabolic rate more quickly, and ultimately improve theprognosis of sepsis patients.
作者 姜芸 吴莉
出处 《中华临床医师杂志(电子版)》 CAS 2016年第7期73-74,共2页 Chinese Journal of Clinicians(Electronic Edition)
关键词 脓毒症 血液滤过 脉冲式高容量血液滤过 sepsis blood filtration pulse high volume blood filtration
  • 相关文献

参考文献11

  • 1Angus DC,Linde-Zwirble WT, Lidicker J,et al: Epidemiology of severesepsis in the United States: Analysis of incidence, outcome, andassociated costs of care[J]. Crit Care Med 2001,29:1303–1310.
  • 2Dellinger RP: Cardiovascular management of septic shock[J]. CritCare Med 2003,31:946–955.
  • 3Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsisin the United States from 1979 through 2000[J]. N Engl J Med 2003,348:1546–1554.
  • 4Linde-Zwirble WT, Angus DC: Severe sepsis epidemiology: Sampling,selection, and society[J].Crit Care 2004, 8:222–226.
  • 5Dombrovskiy VY, Martin AA, Sunderram J, et al: Rapid increase inhospitalization and mortality rates for severe sepsis in the UnitedStates: A trend analysis from 1993 to 2003. Crit Care Med 20.
  • 6Bellomo R, Tipping P, Boyce N. Continuous veno-venoushemofiltration with dialysis removes cytokines from thecirculation of septic patients[J]. Crit Care Med 1993, 21: 522–526.
  • 7Ronco C, Bonello M, Bordoni V et al. Extracorporeal therapies innon-renal disease: treatment of sepsis and the peak concentrationhypothesis[J]. Blood Purif 2004, 22: 164–174.
  • 8Piccinni P, Dan M, Barbacini S et al. Early isovolaemichaemofiltration in oliguric patients with septic shock[J].Intensive Care Med, 2006, 32: 80–86.
  • 9Ratanarat R, Brendolan A, Ronco C. Pulse high-volumehaemofiltration for treatment of severe sepsis: effects onhemodynamics and survival[J]. Crit Care, 2005, 9:294–302.
  • 10Ratanarat R , Brendolan A, Ronco C. Pulse high-volumehaemofiltration in critically ill patients: a new approach forpatients with septic shock[J]. Semin Dial, 2006, 19:69–74.

二级参考文献7

  • 1李文歌.血液净化治疗模式的选择和临床应用[J].中国血液净化,2007,6(4):217-219. 被引量:7
  • 2Ratanarat R, Brendolan A, Ronco C. Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynanics and survival[J]. Crit Care, 2005,9:294 -302.
  • 3Ratanarat R, Brendolan A, Ronco C. Pulse high-volume hemofiltration in critically ill patients: a new approach for patients with septic shock[J]. Semin Dial,2006,19:69 -74.
  • 4Levy MM, Fink MP, Marshall JC, et al. 2001SCCM/ESICM/ACCP/ ATS/SIS JnternatJonal Sepsis Definitions Conference[J].Crit Care Med, 2003,31:1250-1256.
  • 5Delling RP, Leve MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008[J].Cril Care Med, 2008,36: 296-327.
  • 6Bouman CS, Schultz MJ, Vroom MB. Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing[J]. J grit Care, 2007, 22:1 -12.
  • 7毛慧娟,王笑云.脓毒症吸附炎症介质的治疗[J].中国血液净化,2008,7(2):92-95. 被引量:5

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部